Table 1. Resistance profiles of bile isolates of E. coli and Enterococci 2006–2015.

Antibiotic	E. coli (N = 77)	Enterococci (N = 137)
Ceftriaxone	32.5%	n.a.
Ampicillin/Sulbactam	51.9%	32.9%
Piperacillin/Tazobactam	46.8%	n.a.
Quinolones	31.2%	32.8%*
Carbapenems	0%	38.7%
Vancomycin	n.a.	10.2%
Gentamicin	n.a.	32.2%
Linezolid	n.a.	1.5%

*data available for 58 out of 137 isolates; n.a.: not applicable.